Professor Lu was a health economist in the biopharmaceutical industry for 2 decades. He spent more than 16 years at Amgen where, as a director of global health economics, he led a team of health economists on economic evaluation and value dossiers, drug pricing and public policy for new biopharmaceuticals worldwide. Professor Lu is currently a tenured associate professor of economics at the Martin V Smith School of Business and Economics, California State University, Channel Islands, and an adjunct associate professor of health economics at UCLA Fielding School of Public Health, where he runs the Seminar on Pharmaceutical Economics and Policy. Professor Lu has published extensively in pharmaceutical economics, including a recent major policy book: Pharmaceutical Economics and Policy: Perspectives, Promises, and Problems (co-authored with the late Stuart Schweitzer; Oxford University Press, 2018). Professor Lu has also provided economic consulting services to numerous biopharmaceutical firms.